How long a horse lives with squamous cell carcinoma (SCC) depends heavily on where the tumor is and how early it’s caught. For the most common form, ocular SCC around the eyes, median survival is roughly 47 months (about 4 years) with treatment, and many horses live far longer. Gastric SCC, on the other hand, carries a median survival of just weeks. The location of the tumor matters more than almost any other factor.
Ocular SCC: The Most Common and Most Treatable
SCC around the eyes and eyelids is the type most horse owners will encounter. A study of 147 horses treated at Colorado State University found a conservative median survival of 47 months, with a more optimistic estimate reaching 114 months (nearly 10 years). Over 91% of those horses were still alive at the end of the study’s follow-up period, which speaks to how manageable this form can be when addressed early.
Survival varies by the exact location around the eye. Horses with SCC on the third eyelid or inner corner of the eye fared best: over 90% were alive at 29 months. Those with tumors on the limbus (the border between the cornea and the white of the eye) also did well, with nearly 57% still alive at 114 months. Eyelid tumors fell in between, with about 52% alive at 38 months.
Stage at diagnosis is the clearest predictor. Horses with early-stage (stage I) SCC had an 82% survival rate at 47 months. Horses whose tumors had invaded the orbit, the bony socket behind the eye, had a median survival of only 9 months. That’s a dramatic difference and the strongest argument for not ignoring a small pink or white growth near your horse’s eye.
Recurrence Is Common but Manageable
Even after successful removal, ocular SCC comes back frequently. Surgery alone carries a recurrence rate around 44%. Adding radiation therapy after surgery drops that to about 12%, a significant improvement. Most recurrences show up within the first year. In one study of horses treated with surgery plus a slow-release chemotherapy implant, about 18% experienced early recurrence (within a year) and roughly 8% had a late recurrence around the two-year mark.
Recurrence doesn’t necessarily mean a death sentence. Horses that experienced one recurrence had a median survival of 45 months. Even horses with two or three recurrences lived a median of 35 to 36 months. Each recurrence does require another round of treatment, which adds cost and stress, but many horses continue to do well through multiple rounds.
Penile and Genital SCC
SCC of the penis or sheath in geldings and stallions carries a much worse outlook. This form is frequently diagnosed late because the tumors are hidden and easy to miss during routine care. By the time owners notice discharge, swelling, or difficulty urinating, the cancer is often advanced. Poorly differentiated tumors (meaning the cancer cells look highly abnormal under a microscope) are more likely to spread to the inguinal lymph nodes in the groin, and once that happens, treatment becomes much harder.
There are no large survival-time studies for penile SCC comparable to the ocular data, but the veterinary literature consistently describes the prognosis as poor. Euthanasia is a common outcome, driven by late presentation, difficulty achieving clean surgical margins, and progressive decline in the horse’s comfort and ability to urinate normally.
Gastric SCC: The Worst Prognosis
Stomach cancer in horses is rare, but when it occurs, it’s almost always fatal in short order. The median time from the first visible symptoms (weight loss, poor appetite, colic) to death is just 4 weeks. Every horse in the largest published study either died or was euthanized due to the cancer. Gastric SCC is difficult to diagnose early because the signs mimic many other common conditions, and by the time it’s identified, the disease is typically advanced.
Which Horses Are Most at Risk
Certain breeds carry a genetic predisposition. A specific mutation in a DNA-repair gene called DDB2 explains about 76% of ocular SCC cases in Haflingers and Belgians. The same mutation has been identified at lower frequencies in Appaloosas, Percherons, and Rocky Mountain Horses. Breeds frequently reported with higher SCC rates also include Arabians, American Paint Horses, and Quarter Horses.
Coat color plays a role too. Across multiple breeds, between 32% and 46% of affected horses had a chestnut base coat, and lighter skin around the eyes, muzzle, or genitals is a known risk factor. UV exposure amplifies the risk, which is why SCC is more common in horses living at higher altitudes or in sunny climates, and why tumors cluster on unpigmented skin.
There’s also a sex difference. In Belgians, males were significantly overrepresented among SCC cases compared to unaffected horses. For penile SCC specifically, the risk is obviously limited to geldings and stallions, but older geldings appear disproportionately affected.
What Drives the Decision to Euthanize
Most horses with cancer do not die naturally from the disease. Euthanasia typically happens before that point, when the horse’s quality of life deteriorates beyond what treatment can restore. Veterinarians and owners often use a structured quality-of-life assessment that scores seven categories: pain control, appetite, hydration, hygiene, happiness (responsiveness and engagement), mobility, and whether the horse has more good days than bad. Each is scored on a 0 to 10 scale, and a combined score of 35 or higher suggests acceptable quality of life.
For ocular SCC, the tipping point often comes when the tumor invades the orbit, causing chronic pain, vision loss, or facial deformity that can’t be managed. For penile SCC, it’s usually progressive difficulty urinating or uncontrollable local infection. For gastric SCC, rapid weight loss and unrelenting colic leave little room for intervention. The scale gives owners an objective framework for a deeply subjective decision, helping separate emotion from the horse’s actual daily experience.
Practical Takeaways for Owners
If your horse has been diagnosed with SCC around the eye, the numbers are genuinely encouraging, especially with early detection. Many of these horses live four to ten years or longer after treatment. Combining surgery with radiation therapy cuts recurrence risk dramatically and is worth discussing with your veterinarian if it’s available in your area.
For penile or gastric SCC, the picture is harder. Early detection of penile tumors through regular sheath cleaning and inspection gives the best chance of a meaningful outcome. Gastric SCC is largely unpreventable and carries a timeline measured in weeks, not months.
Across all types, catching the tumor when it’s small and localized is the single most important factor. A small, slow-growing bump near the eye at stage I is a treatable problem. The same cancer at stage IV, invading the orbit, is a life-limiting one. Regular veterinary exams and owner awareness of new growths on unpigmented skin are the most effective tools available.